IMMUNOLOGICAL LOOK AT THE TREATMENT OF CORONAVIRUS COVID-19 AND SARS-2 INFECTIONS release_pdexai5sufgfjpgxh7aj4oe3m4

by V. E. Kazmurchuk, A. Yu. Galkin

Published in Likarska sprava by LLC Information and Research Center Likarska Sprava.

Issue 1-2 p3-7 (2020)

Abstract

The article outlines the causes of deaths when using a combination of azithromycin with Plaquenil®. Immunological substantiation of the main factors leading to vascular and pulmonary pathology (triggering angiotensin-converting enzyme and helper aggression in the lungs) is given. An immunotherapy method that eliminates the etiological links of the processes occurring during COVID-19 viremia is proposed. The method of prophylaxis of personnel in contact with patients is to use specific antibodies to coronaviruses found in immunoglobulin with intramuscular injection. A treatment schema for severe patients with COVID-19, SARS-2 is proposed.
In application/xml+jats format

Archived Files and Locations

application/pdf  268.4 kB
file_wwwd44maenbgnesk3epokwbv54
web.archive.org (webarchive)
liksprava.com (publisher)
Read Archived PDF
Archived
Type  article-journal
Stage   published
Date   2020-03-30
Container Metadata
Not in DOAJ
Not in Keepers Registry
ISSN-L:  1019-5297
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 00e60793-9848-4157-b22f-5d2c9fc4a789
API URL: JSON